TABLE 3.
Animal no. | Virus | Genotype | Time to death (h) | Spreada | Symptomb | Plaque sizec | Endocytosisd |
---|---|---|---|---|---|---|---|
99-AB17 | PRV Bee | Wild type | 70.3 | +++ | Wild type | +++ | +++ |
99-AB18 | PRV Be | Wild type | 63.6 | +++ | Wild type | +++ | +++ |
99-AB10 | PRV 162 | del 46–55 | 79.5 | − | Attenuated | +++ | −f |
99-AB11 | PRV 162 | del 46–55 | 75.8 | − | Attenuated | +++ | − |
99-AB12 | PRV 162 | del 46–55 | 73.0 | − | Attenuated | +++ | − |
99-AB15 | PRV 166 | L30–31A | 74.8 | +++ | Wild type | +++ | ++f |
99-AB16 | PRV 166 | L30–31A | 64.4 | +++ | Wild type | +++ | ++ |
99-AB25 | PRV 170 | Y49–50A S51A S53A | 86.6 | − | Attenuated | +++g | − |
99-AB26 | PRV 170 | Y49–50A S51A S53A | 68.7 | − | Attenuated | +++ | − |
99-AB33 | PRV 170 | Y49–50A S51A S53A | 98.3 | − | Attenuated | +++ | − |
99-AB34 | PRV 170 | Y49–50A S51A S53A | 96.8 | − | Attenuated | ||
99-AB27 | PRV 171 | E52A D54A N55A E56A | 113.6 | ++ | Attenuated | +++g | + |
99-AB28 | PRV 171 | E52A D54A N55A E56A | 86.8 | − | Attenuated | +++ | + |
99-AB35 | PRV 171 | E52A D54A N55A E56A | 77.9 | − | Attenuated | +++ | + |
99-AB36 | PRV 171 | E52A D54A N55A E56A | 68.2 | − | Attenuated | +++ | + |
99-AB29 | PRV 172 | Y49–50A | 85.3 | − | Attenuated | +++g | ++ |
99-AB30 | PRV 172 | Y49–50A | 73.5 | − | Attenuated | +++ | ++ |
99-AB37 | PRV 172 | Y49–50A | 87.3 | − | Attenuated | +++ | ++ |
99-AB38 | PRV 172 | Y49–50A | 78.3 | − | Attenuated | ||
99-AB31 | PRV 173 | S51A S53A | 70.3 | − | Attenuated | +++g | + |
99-AB32 | PRV 173 | S51A S53A | 84.0 | + | Attenuated | +++ | + |
99-AB39 | PRV 173 | S51A S53A | 71.5 | − | Attenuated | +++ | + |
99-AB40 | PRV 173 | S51A S53A | 74.0 | − | Attenuated | +++ | + |
Relative amount of PRV viral antigen found in the SC and DGN compared to that found after PRV Be infection. +++, amount found after PRV Be infection.
Wild-type versus attenuated symptoms have been described previously (7).
Relative sizes of plaques measured 48 h after infection compared to sizes of plaques formed by PRV Be (+++).
Endocytosis was examined by antibody uptake assays and indirect immunofluorescence internalization assays (data not shown) on PK15 cells stably expressing the various mutant Us9-EGFP fusion proteins. The relative amount of the mutant Us9–EGFP fusion proteins internalized is compared to that of wild-type Us9–EGFP (+++).
The data for animals infected with PRV Be have been reported previously and are included for comparison (7).
The endocytosis phenotypes for PRV 162 and PRV 166 have been described previously (8).
Data not shown.